. MeV infection of AML cell lines alters at 1, 2, 3 and 4 dpi. The indicated cell lines were infected with MeV-GFP or MOCK-infected. (A) Gating strategy used to characterize AML cells by flow cytometry. (B) At 24, 48, 72 and 96 hpi the percentage of GFP-expressing cells was determined by FACS. One representative result out of two experiments with similar results is shown. AML, acute myeloid leukemia; MeV, measles vaccine virus; dpi, days post-infection; hpi, hours post-infection.
. MeV infection of AML cells alters at 1, 2, 3 and 4 dpi. The indicated cell lines were infected with MeV-GFP. Representative photomicrographs (top row of each panel, transmission images; bottom row of each panel, fluorescence microscopy images; x10 magnification) of (A) AML cell lines or (B) PBMCs from the indicated patients with AML were taken at 24, 48, 72 and 96 hpi. AML, acute myeloid leukemia; MeV, measles vaccine virus; dpi, days post-infection; hpi, hours post-infection; UPN, unique patient number; PBMCs, peripheral blood mononuclear cells. Figure S3 . PBMCs from patients with AML release IFN-β upon infection with MeV-GFP. PBMC from UPN 1 and UPN 2 were infected with MeV-GFP at MOI of 10 or MOCK infected. Supernatants were harvested at the indicated time points post-infection. IFN-β expression was determined by ELISA (to enable comparison, dotted horizontal lines indicate a level of 200 pg IFN-β in both graphs). AML, acute myeloid leukemia; MeV, measles vaccine virus; dpi, days post-infection; UPN, unique patient number; PBMCs, peripheral blood mononuclear cells.
